Delivery Order SPE2DB20D3505-SPE2DB24FU7C3

Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Latuda 60 mg tablets to the Defense Logistics Agency (DLA). The $1,536.39 firm fixed-price contract was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 7, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of Latuda 20 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $2,868.83 and was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order with a firm fixed price and has an ultimate completion date of August 17, 2023. This contract is not set aside for any particular business type. It appears to be part of a larger Indefinite Delivery...
This federal contract award is for the delivery of Latuda 80 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical, a division of the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,352.68 and is a firm fixed-price delivery order, with an ultimate completion date of May 15, 2023. The contract was awarded on May 12, 2023 and does not have a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,043.94 delivery order is for the supply of Latuda 60 mg tablets and has a completion date of October 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $3,200.25, is for the delivery of Latuda 60 mg tablets. It is a firm-fixed price delivery order contract with a period of performance through November 14, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of Latuda 80 mg tablets to the Defense Logistics Agency (DLA). The $1,975.67 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The company holds...
This federal contract award is for the delivery of Latuda 20 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $4,173.91 and a completion date of February 23, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,438.88 firm fixed-price delivery order is for the supply of Latuda 40 mg tablets. The contract has an ultimate completion date of April 15, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Latuda 120 mg tablets. The contract has a ceiling value of $2,548.62 and a period of performance through August 25, 2023. It is a firm-fixed-price delivery order contract, with no set-aside requirements indicated. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,379.30, is for the delivery of Latuda 80 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of December 19, 2024. The award was made on December 18, 2024, and does not have a set-aside designation, indicating open competition....
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB24FU7C3
    Delivery Order

This federal contract award is for the delivery of Latuda 60 mg tablets to the Defense Logistics Agency (DLA). The $2,896.95 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 30, 2024 with a completion date of July 31, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 to provide a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical commodities.

Generated 2/27/25, 10:26 AM